 | Kojic acid | IC50 | 66550.0 [1] |
 | Kojic acid | Ki | 350000.0 [1] |
 | Arbutin | IC50 | 30260.0 [1], 230000.0 [2], 32000000.0 [3] |
 | 2-Hydroxypyridine 1-oxide | IC50 | 150000.0 [1], 1300000.0 [2] |
 | 2-Hydroxypyridine 1-oxide | Ki | 128000.0 [1] |
 | 1-Hydroxy-5-[(Z)-(6-hydroxy-3-oxo-1-benzofuran-2-ylidene)methyl]pyridin-2-one | IC50 | 16600.0 [1], 85300.0 [2] |
 | 1-Hydroxy-5-[(Z)-(6-hydroxy-3-oxo-1-benzofuran-2-ylidene)methyl]pyridin-2-one | Ki | 350.0 [1] |
 | 5-[(Z)-(4,6-Dihydroxy-3-oxo-1-benzofuran-2-ylidene)methyl]-1-hydroxypyridin-2-one | IC50 | 34000.0 [1], 119000.0 [2] |
 | 1-Hydroxy-5-[(Z)-(4-hydroxy-3-oxo-1-benzofuran-2-ylidene)methyl]pyridin-2-one | IC50 | 30000.0 [1], 120000.0 [2] |
 | Ascorbic acid | IC50 | 32500.0 [1] |
 | Levodopa | IC50 | 8400000.0 [1] |
 | Resveratrol | IC50 | 3680000.0 [1] |
 | Kaempferol | IC50 | 1000.0 [1] |
 | Benzaldehyde | IC50 | 820000.0 [1] |
 | 4-Hydroxybenzoic acid | IC50 | 9350.0 [1] |
 | Phenylthiourea | IC50 | 1800.0 [1] |
 | Salicylaldehyde | IC50 | 3300000.0 [1] |
 | Tert-Butylhydroquinone | IC50 | 54200.0 [1] |
 | Umbelliferone | IC50 | 420000.0 [1] |
 | 4-Methoxybenzaldehyde | IC50 | 320000.0 [1] |
 | Hexylresorcinol | IC50 | 560.0 [1] |
 | Glabridin | IC50 | 90.0 [1] |
 | Oxyresveratrol | IC50 | 12700.0 [1] |
 | 2-Hydroxy-4-methoxybenzaldehyde | IC50 | 30000.0 [1] |
 | 4-Isopropylbenzaldehyde | IC50 | 50000.0 [1] |
 | 2,3',4,5'-Tetramethoxystilbene | IC50 | 100000.0 [1] |
 | (1E,4E)-1,5-Bis(4-hydroxy-3-methoxyphenyl)penta-1,4-dien-3-one | IC50 | 250000.0 [1] |
 | Norartocarpetin | IC50 | 23.0 [1] |
 | 1,5-Bis(4-hydroxyphenyl)penta-1,4-dien-3-one | IC50 | 79050.0 [1] |
 | Hispidol | IC50 | 38400.0 [1] |
 | Glyasperin D | IC50 | 154.0 [1] |
 | 2,6-Bis(4-hydroxybenzylidene)cyclohexanone | IC50 | 250000.0 [1] |
 | Glabrene | IC50 | 7500.0 [1] |
 | 7-Hydroxy-3-phenyl-2H-chromen-2-one | IC50 | 10000000.0 [1] |
 | (1E,4E)-1,5-Bis(4-fluorophenyl)penta-1,4-dien-3-one | IC50 | 250000.0 [1] |
 | 2,4,6-Cycloheptatrien-1-one, 2-hydroxy-3-(1-methylethyl)- | IC50 | 1000000.0 [1] |
 | 4-Isopropylsalicylaldehyde | IC50 | 2300.0 [1] |
 | 2,6-Bis(4-chlorobenzylidene)cyclohexanone | IC50 | 250000.0 [1] |
 | Glyasperin C | IC50 | 177.0 [1] |
 | (Z)-4,6-Dihydroxy-2-(4-hydroxybenzylidene)benzofuran-3(2H)-one | IC50 | 38000.0 [1] |
 | (Z)-2-(4-Hydroxybenzylidene)-4-hydroxybenzofuran-3(2H)-one | IC50 | 31700.0 [1] |
 | 4-[2-(3,5-Dihydroxyphenyl)ethyl]benzene-1,3-diol | IC50 | 1600.0 [1] |
 | 4-[2-(2,4-Dihydroxyphenyl)ethyl]benzene-1,3-diol | IC50 | 370.0 [1] |
 | 3-(3,5-Dihydroxyphenyl)-7-hydroxycoumarin | IC50 | 10000000.0 [1] |
 | 1-[3-[(1R)-1-[3-Acetyl-2,6-dihydroxy-4-methoxy-5-(3-methylbut-2-enyl)phenyl]-3-methylbutyl]-2,4,6-trihydroxy-5-(3-methylbut-2-enyl)phenyl]ethanone | IC50 | 333000.0 [1] |
 | 4-Hydroxyphenethyl 3,4,5-trihydroxybenzoate | IC50 | 4930.0 [1] |
 | Fortuneanoside E | IC50 | 140000.0 [1] |
 | 1,5-Bis(2-fluoro-4-methoxyphenyl)penta-1,4-dien-3-one | IC50 | 250000.0 [1] |
 | 1-[2-(2,4-Dimethoxyphenyl)ethyl]-3,5-dimethoxybenzene | IC50 | 100000.0 [1] |
 | (2S,3R,4S,5R)-2-[2-[2-(2,4-Dihydroxyphenyl)ethyl]-5-hydroxyphenoxy]oxane-3,4,5-triol | IC50 | 1600.0 [1] |
 | (2S,3R,4S,5R)-2-[4-[2-(2,4-Dihydroxyphenyl)ethyl]-3-hydroxyphenoxy]oxane-3,4,5-triol | IC50 | 430.0 [1] |
 | (2S,3R,4S,5R)-2-[4-[2-(2,4-Dihydroxyphenyl)ethyl]-3-[(2S,3R,4S,5R)-3,4,5-trihydroxyoxan-2-yl]oxyphenoxy]oxane-3,4,5-triol | IC50 | 730.0 [1] |
 | Bryoamaride | IC50 | 85010.0 [1] |
 | 3,5-Dihydroxy-N-[2-(6-hydroxy-1H-indol-3-yl)ethyl]benzamide | IC50 | 9100.0 [1] |
 | (2S,3R,4S,5R)-2-[(2S)-4-(2,4-Dihydroxyphenyl)butan-2-yl]oxyoxane-3,4,5-triol | IC50 | 4560.0 [1] |
 | (2S,3R,4S,5S,6R)-2-[(2R,3S,4R,5R,6R)-6-[(2R)-4-(2,4-Dihydroxyphenyl)butan-2-yl]oxy-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol | IC50 | 1510.0 [1] |
 | (2S,3R,4S,5S,6R)-2-[(2R,3S,4R,5R,6R)-6-[(2S)-4-(2,4-Dihydroxyphenyl)butan-2-yl]oxy-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol | IC50 | 3830.0 [1] |
 | (2R,3R,4S,5S,6R)-2-[(2R)-4-(2,4-Dihydroxyphenyl)butan-2-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol | IC50 | 2300.0 [1] |
 | (2R,3R,4S,5S,6R)-2-[(2S)-4-(2,4-Dihydroxyphenyl)butan-2-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol | IC50 | 4720.0 [1] |
 | (2S,3R,4S,5R)-2-[(2R)-4-(2,4-Dihydroxyphenyl)butan-2-yl]oxyoxane-3,4,5-triol | IC50 | 1720.0 [1] |
 | (2S)-2-[[(2S)-2-[[(2S)-2-[(5-Hydroxy-4-oxopyran-2-yl)methoxycarbonylamino]-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-3-(4-hydroxyphenyl)propanoic acid | IC50 | 330.0 [1] |
 | (2S)-2-[[(2S)-2-[[(2S)-2-[(5-Hydroxy-4-oxopyran-2-yl)methoxycarbonylamino]-3-phenylpropanoyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]-3-(4-hydroxyphenyl)propanoic acid | IC50 | 240.0 [1] |
 | Fortuneanoside B | IC50 | 2210000.0 [1] |
 | Fortuneanoside D | IC50 | 70000.0 [1] |
 | 4-[(3S)-3-Hydroxybutyl]benzene-1,3-diol | IC50 | 2170.0 [1] |
 | 4-[(3R)-3-Hydroxybutyl]benzene-1,3-diol | IC50 | 1780.0 [1] |
 | 7-(2,4-Dihydroxyphenyl)-2,2-dimethylpyrano[3,2-g]chromen-8-one | IC50 | 2800.0 [1] |
 | 7-Hydroxy-3-(2-hydroxy-4-methoxyphenyl)-8-(3-methylbut-2-enyl)-2,3-dihydrochromen-4-one | IC50 | 5100.0 [1] |
 | Cycloorbicoside G | IC50 | 54640.0 [1] |
 | 2-[4,5-Dihydroxy-2-methoxy-3-(3-methylbut-2-enyl)phenyl]-5,7-dihydroxy-3-(3-methylbut-2-enyl)chromen-4-one | IC50 | 45300.0 [1] |
 | Cyclocarposide | IC50 | 102390.0 [1] |
 | Askendoside D | IC50 | 48920.0 [1] |
 | 3-Hydroxyphenethyl 3,4,5-trihydroxybenzoate | IC50 | 15210.0 [1] |
 | 2-Hydroxyphenethyl 3,4,5-trihydroxybenzoate | IC50 | 14500.0 [1] |
 | (2S)-2-[[(2S)-2-[[(2S)-2-[(5-Hydroxy-4-oxopyran-2-yl)methoxycarbonylamino]-3-phenylpropanoyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]butanedioic acid | IC50 | 2130.0 [1] |
 | (2S)-2-[[(2S)-2-[[(2S)-2-[(5-Hydroxy-4-oxopyran-2-yl)methoxycarbonylamino]-3-phenylpropanoyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]-3-(1H-indol-3-yl)propanoic acid | IC50 | 6170.0 [1] |
 | (2S)-2-[[(2S)-2-[[(2S)-2-[(5-Hydroxy-4-oxopyran-2-yl)methoxycarbonylamino]-3-phenylpropanoyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]-3-phenylpropanoic acid | IC50 | 4480.0 [1] |
 | (2S)-2-[[(2S)-2-[[(2S)-2-[(5-Hydroxy-4-oxopyran-2-yl)methoxycarbonylamino]-3-phenylpropanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]-3-(4-hydroxyphenyl)propanoic acid | IC50 | 390.0 [1] |
 | (2S)-2-[[(2S)-2-[[(2S)-2-[(5-Hydroxy-4-oxopyran-2-yl)methoxycarbonylamino]-3-(1H-indol-3-yl)propanoyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]-3-(4-hydroxyphenyl)propanoic acid | IC50 | 780.0 [1] |
 | (2S,3S)-2-[[(2S)-2-[[(2S)-2-[(5-Hydroxy-4-oxopyran-2-yl)methoxycarbonylamino]-3-phenylpropanoyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]-3-methylpentanoic acid | IC50 | 2180.0 [1] |
 | Askendoside B | IC50 | 13950.0 [1] |
 | Cyclosieversioside | IC50 | 92250.0 [1] |
 | Gnetucleistol D | IC50 | 100000.0 [1] |
 | 4-[(E)-2-(3-Hydroxy-5-methoxyphenyl)ethenyl]-3-methoxyphenol | IC50 | 100000.0 [1] |
 | 2-[(E)-2-(3-Hydroxy-5-methoxyphenyl)ethenyl]-5-methoxyphenol | IC50 | 100000.0 [1] |
 | Fortuneanoside C | IC50 | 450000.0 [1] |
 | (2S,3R,4S,5S,6R)-2-[4-[2-(2,4-Dihydroxyphenyl)ethyl]-3-hydroxyphenoxy]-6-(hydroxymethyl)oxane-3,4,5-triol | IC50 | 770.0 [1] |
 | (2S,3R,4S,5S,6R)-2-[(2R,3S,4R,5R,6S)-6-[4-[2-(2,4-Dihydroxyphenyl)ethyl]-3-hydroxyphenoxy]-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol | IC50 | 680.0 [1] |
 | (2R,3R,4S,5S,6R)-2-[(2R,3S,4R,5R,6S)-6-[4-[2-(2,4-Dihydroxyphenyl)ethyl]-3-hydroxyphenoxy]-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol | IC50 | 830.0 [1] |
 | cis-2,4,3',5'-Tetramethoxystilbene | IC50 | 100000.0 [1] |
 | (2R,3R,4S,5S,6R)-2-[(2R,3S,4R,5R,6R)-6-[(2R)-4-(2,4-Dihydroxyphenyl)butan-2-yl]oxy-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol | IC50 | 1980.0 [1] |
 | (2R,3R,4S,5S,6R)-2-[(2R,3S,4R,5R,6R)-6-[(2S)-4-(2,4-Dihydroxyphenyl)butan-2-yl]oxy-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol | IC50 | 4130.0 [1] |
 | (S)-2-(5-Hydroxy-4-oxo-4H-pyran-2-ylmethoxycarbonylamino)-propionic acid | IC50 | 23210.0 [1] |
 | (5-Hydroxy-4-oxopyran-2-yl)methyl (2S)-2-[(5-hydroxy-4-oxopyran-2-yl)methoxycarbonylamino]propanoate | IC50 | 3030.0 [1] |
 | (2S)-2-[(5-Hydroxy-4-oxopyran-2-yl)methoxycarbonylamino]-4-methylpentanoic acid | IC50 | 14510.0 [1] |
 | (5-Hydroxy-4-oxopyran-2-yl)methyl (2S)-2-[(5-hydroxy-4-oxopyran-2-yl)methoxycarbonylamino]-4-methylpentanoate | IC50 | 2000.0 [1] |
 | (5-Hydroxy-4-oxopyran-2-yl)methyl (2S)-2-[(5-hydroxy-4-oxopyran-2-yl)methoxycarbonylamino]-3-phenylpropanoate | IC50 | 60.0 [1] |
 | (5-Hydroxy-4-oxopyran-2-yl)methyl (2S)-2-[(5-hydroxy-4-oxopyran-2-yl)methoxycarbonylamino]-3-methylbutanoate | IC50 | 2390.0 [1] |
 | (2S)-2-[(5-Hydroxy-4-oxopyran-2-yl)methoxycarbonylamino]-3-phenylpropanoic acid | IC50 | 8000.0 [1] |
 | (2S)-2-[(5-Hydroxy-4-oxopyran-2-yl)methoxycarbonylamino]-3-methylbutanoic acid | IC50 | 16660.0 [1] |